abstract |
Described herein includes 2- (3-((7- (3- (ethyl (2-hydroxyethyl) amino) propoxy) quinazolin-4-yl) amino) -1H-pyrazole-5 -N- (3-fluorophenyl) acetamidamine (also known as AZD1152 hqpa) or a polymeric nanoparticle of a therapeutic agent for a pharmaceutically acceptable salt thereof, and the manufacture and use of such therapeutic nanoparticle Method. |